Evidence map›Paper›PMID 33301427›Full record

ArticleThe Journal of clinical investigation2021

The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas.

Bidisha Bhattacharya, Shiqi Xiao, Sujoy Chatterjee, Michael Urbanowski, Alvaro Ordonez, Elizabeth A Ihms, Garima Agrahari, Shichun Lun, Robert Berland, Alexander Pichugin and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Bidisha BhattacharyaThe National Emerging Infectious Diseases Laboratory, Boston University School of Medicine, Boston, Massachusetts, USA.
Shiqi XiaoCenter for TB Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sujoy ChatterjeeThe National Emerging Infectious Diseases Laboratory, Boston University School of Medicine, Boston, Massachusetts, USA.
Michael UrbanowskiCenter for TB Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Alvaro OrdonezCenter for TB Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Elizabeth A IhmsCenter for TB Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Garima AgrahariThe National Emerging Infectious Diseases Laboratory, Boston University School of Medicine, Boston, Massachusetts, USA.
Shichun LunCenter for TB Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Robert BerlandThe National Emerging Infectious Diseases Laboratory, Boston University School of Medicine, Boston, Massachusetts, USA.
Alexander PichuginDepartment of Cellular Immunology, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Yuanwei GaoDepartment of Pharmacokinetics, Pharmacodynamics & Drug Metabolism (PPDM), Merck, West Point, Pennsylvania, USA.
John ConnorDepartment of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Alexander R IvanovDepartment of Chemistry & Chemical Biology, Northeastern University, Boston, Massachusetts, USA.
Bo-Shiun YanInstitute of Biochemistry and Molecular Biology, National Taiwan University Medical College, Zhongzheng District, Taipei City, Taiwan.
Lester KobzikHarvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Bang-Bon KooThe National Emerging Infectious Diseases Laboratory, Boston University School of Medicine, Boston, Massachusetts, USA.
Sanjay JainCenter for TB Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
William BishaiCenter for TB Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Igor KramnikThe National Emerging Infectious Diseases Laboratory, Boston University School of Medicine, Boston, Massachusetts, USA.
Boston University · USJohns Hopkins University · USHarvard University · USNational Taiwan University · TWNortheastern University · USUnited States Military Academy · USWalter Reed Army Institute of Research · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapiesR01HL126066 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KRAMNIK, IGOR, NIEDERWEIS, MICHAEL · 2016 to 2025
$5.6M
Measuring Intralesional Drug Exposures in Cavitary TB using Noninvasive In Vivo PET ImagingR01AI153349 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JAIN, SANJAY · 2020 to 2024
$3.8M
Novel Imaging Tracers for Rapid and Noninvasive Assessment of Bacterial InfectionR01EB020539 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI JAIN, SANJAY · 2014 to 2018
$3.6M
Aberrant immune activation in the tuberculosis granuloma: a pivotal role in necrosisR01HL133190 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BISHAI, WILLIAM RAMSES, KRAMNIK, IGOR · 2016 to 2019
$3.0M
NCATS NIH HHS UL1 TR001430NHLBI NIH HHS R01 HL126066NHLBI NIH HHS R01 HL133190NIAID NIH HHS R01 AI153349NIBIB NIH HHS R01 EB020539
6 · The paper itself

Abstract

The mechanism by which only some individuals infected with Mycobacterium tuberculosis develop necrotic granulomas with progressive disease while others form controlled granulomas that contain the infection remains poorly defined. Mice carrying the sst1-suscepible (sst1S) genotype develop necrotic inflammatory lung lesions, similar to human tuberculosis (TB) granulomas, which are linked to macrophage dysfunction, while their congenic counterpart (B6) mice do not. In this study we report that (a) sst1S macrophages developed aberrant, biphasic responses to TNF characterized by superinduction of stress and type I interferon pathways after prolonged TNF stimulation; (b) the late-stage TNF response was driven via a JNK/IFN-β/protein kinase R (PKR) circuit; and (c) induced the integrated stress response (ISR) via PKR-mediated eIF2α phosphorylation and the subsequent hyperinduction of ATF3 and ISR-target genes Chac1, Trib3, and Ddit4. The administration of ISRIB, a small-molecule inhibitor of the ISR, blocked the development of necrosis in lung granulomas of M. tuberculosis-infected sst1S mice and concomitantly reduced the bacterial burden. Hence, induction of the ISR and the locked-in state of escalating stress driven by the type I IFN pathway in sst1S macrophages play a causal role in the development of necrosis in TB granulomas. Interruption of the aberrant stress response with inhibitors such as ISRIB may offer novel host-directed therapy strategies.

Indexed as

AnimalsDisease Models, AnimalGranuloma, Respiratory TractLungMiceMice, SCIDMycobacterium tuberculosisNecrosisStress, PhysiologicalTuberculosis, PulmonaryImmunologyInfectious diseaseTuberculosis

Identifiers

PMID33301427
PMCPMC7843230
OpenAlexW3110971871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.